Used primarily in research settings as a selective antagonist for androgen receptors, this compound helps in studying hormone-dependent processes, particularly in prostate cancer models. It is valuable in investigating the mechanisms of androgen receptor signaling and in developing therapies targeting androgen-sensitive tissues. Due to its structural specificity and receptor binding properties, it is also employed in radiolabeled forms for receptor binding assays and imaging studies. Its application remains confined to laboratory and preclinical research, with no current therapeutic use in humans.